Hemp Logix

Xellia Pharmaceuticals is a global leader in manufacturing fermentation-based non-beta-lactam anti-infectives, providing essential active pharmaceutical ingredients (APIs) and Finished Dosage Forms (FDFs) to over 500 pharmaceutical companies across 80 countries. Recognized by the World Health Organization and the European Union, their products play a crucial role in combating severe infections and addressing antimicrobial resistance. Headquartered in Copenhagen, Denmark, Xellia boasts a rich legacy of over 120 years in the pharmaceutical industry, with manufacturing sites in Denmark, Hungary, and China. As the sole European manufacturer of several of its products, the company maintains a strong global presence with R&D and commercial operations spanning eight additional locations worldwide. Generated from the website